---

---

tags : Biotech-bay   

save search

---

Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
ACET | News | $2.08 4.0% 420K |

Health Technology

| 2.56% | O: 2.56% H: 2.0% C: 0.0%
adi-270 presentation cell preclinical for meeting therapy

---

Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
SPRB | News | $0.692 -1.2% -1.49% 21K |

Health Technology

| -1.43% | O: -2.86% H: 2.94% C: 1.47%
presentation endocrine meeting

---

New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Published: 2024-04-22 (Crawled : 17:00) - biospace.com/
VCYT | News | $19.85 2.06% 2.02% 5 |

Health Technology

| 2.06% | O: 1.03% H: 2.65% C: 1.02%
active test cancer for study

---

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
GH | News M | $17.57 -0.11% 59K |

Health Services

| 9.46% | O: 4.42% H: 5.36% C: 4.83%
fda test review cancer blood for

---

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
TWST | $29.45 5.37% 5.22% 400 |

Health Technology

| 3.08% | O: -0.04% H: 0.0% C: 0.0%
report bioscience financial results

---

Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
Published: 2024-04-16 (Crawled : 00:00) - biospace.com/
EXEL | $22.87 1.55% 1.49% 0 |

Health Technology

| 0.75% | O: -0.62% H: 0.0% C: 0.0%
first financial results

---

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
GIA | $1.08 237.96% 1.4K |

| Email alert Add to watchlist
breast technology trial imaging

---

Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Published: 2024-04-15 (Crawled : 14:00) - biospace.com/
A | $136.74 2.11% 72K |

Health Technology

| -4.85% | O: 1.12% H: 0.66% C: -1.47%
certification assay for

---

Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
Published: 2024-04-15 (Crawled : 14:00) - biospace.com/
OM | $2.395 2.35% 48K |

Health Technology

| 14.15% | O: 0.0% H: 2.93% C: -0.49%
association care medical

---

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2024
Published: 2024-04-11 (Crawled : 07:00) - biospace.com/
MIRM | $24.17 1.51% 1.49% 0 |

Health Technology

| -5.59% | O: -0.35% H: 1.98% C: 1.25%
nasdaq pharmaceuticals grants

---

Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Published: 2024-04-09 (Crawled : 14:30) - biospace.com/
VTGN | $4.78 0.42% 0.63% 1.3K |

Health Technology

| -7.54% | O: 0.58% H: 3.65% C: 3.27%
conference association depression

---

Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 22:00) - biospace.com/
ACLX | $52.0 1.7K |

| -17.72% | O: -0.13% H: 2.16% C: -1.76%
conference

---

Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
GH | News M | $17.57 -0.11% 59K |

Health Services

| -15.39% | O: -0.14% H: 4.43% C: -5.11%
precision health meeting application

---

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
ANNX | $4.545 9.2K |

Health Technology

| -29.28% | O: 0.78% H: 3.86% C: -0.31%
conference

---

Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
A | $136.74 2.11% 72K |

Health Technology

| -7.12% | O: -0.28% H: 0.75% C: -0.03%
cancer research diagnostics

---

Nurix Therapeutics to Participate in Upcoming Investor Conferences - April 03, 2024
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
NRIX 6 d | $14.04 3.39% 38K |

Health Technology

| -8.61% | O: -1.28% H: 0.68% C: -0.55%
therapeutics

---

Infinant Health Announces Submission of Orphan Drug Designation Application
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.88 -0.16% 940K |

Health Technology

| -5.49% | O: -0.77% H: 0.8% C: 0.74%
drug health designation application submission

---

Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JAGX | News | $0.1611 -10.45% 14M |

Health Technology

| 133.77% | O: -4.68% H: 0.82% C: 0.82%
health international

---

Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
BMY | $49.12 -0.04% 170K |

Health Technology

| -7.27% | O: 0.21% H: 0.47% C: -0.68%
report

---

Jaguar Health Reports 2023 Financial Results
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
JAGX | News | $0.1611 -10.45% 14M |

Health Technology

| 100.22% | O: 0.0% H: 0.0% C: -14.35%
health financial results

---

Gainers vs Losers

74%

26%

Top 10 Gainers

MTTR | News M | $4.625 165.81% 5.5M |

AGBA | $2.615 109.2% 14M |

Finance

EDBL | News | $7.37 96.01% 650K |

OPRT | News | $3.19 41.78% 3M |

Finance

MLEC | $1.87 33.57% 1.6M |

n/a

ATGL | $3.66 27.97% 150K |

KULR | $0.5446 22.0% 6.8M |

Manufacturing

MDIA 4 | $2.205 21.15% 150K |

Consumer Services

LYT | $4.96 20.68% 610K |

HIBB 4 | $85.785 18.34% 1M |

Retail Trade

---

Your saved searches

---